When Lyme Becomes
Multi-System Chaos

MCAS. Dysautonomia. Autoimmunity. Neuroinflammation. These aren't separate diseases  they're patterns of a terrain in crisis. Here is how they connect.

By Brehan Crawford, MAcOM, LAc

Why you keep collecting diagnoses

If you've been dealing with chronic Lyme long enough, you've probably noticed something: the diagnosis list keeps growing. First it was Lyme. Then mast cell activation. Then POTS or some flavor of dysautonomia. Then maybe Hashimoto's. Maybe small fiber neuropathy. Maybe CIRS.

Each diagnosis comes with its own specialist, its own supplement stack, its own protocol. And nobody connects them. You end up managing five conditions independently when what you actually have is one destabilized terrain expressing itself across multiple systems.

This is Part 4 of a five-part series on the Lyme Remission Map masterclass. Today I'm going to walk through the four multi-system patterns I encounter most often  how they develop, how they interconnect, and why treating them separately usually makes things worse.

Mast cell activation: when the alarm won't stop

Mast cell activation syndrome has become the diagnosis du jour in the chronic illness world, and I understand why — the symptoms are real, the suffering is real, and people are desperate for an explanation. But most practitioners are treating MCAS like it's a standalone condition, throwing antihistamines and mast cell stabilizers at the problem without asking: why are the mast cells overactivated in the first place?

In chronic Lyme, the answer is usually a convergence: gut permeability from prolonged dysbiosis, fatty liver from metabolic strain, ongoing infectious load from organisms the immune system can't clear, and a terrain that's been stressed beyond its capacity to self-regulate. The mast cells aren't malfunctioning — they're responding to a genuine crisis. Suppressing their signal without addressing the source is like disconnecting your smoke detector while the kitchen is on fire.

Our approach starts before internal herbs: botanical foot soaks to gently introduce plant compounds through the skin without taxing a reactive gut, paired with breathwork to regulate vagal tone and abdominal self-massage to support lymphatic movement. These aren't wellness fluff — they're clinical tools that reduce mast cell reactivity enough for the gut to tolerate the next phase of treatment.

Dysautonomia: the nervous system that can't regulate

Heart rate spikes when you stand up. Dizziness that comes and goes. Feeling wired and exhausted simultaneously. Temperature instability. Exercise intolerance that seems disproportionate to anything objective. This is the dysautonomia pattern, and it's nearly universal in chronic Lyme.

Here's what most people don't realize about the vagus nerve: roughly 80% of its fibers are afferent — meaning they carry information from the body to the brain, not the other direction. Your vagus nerve is primarily a sensory nerve. It's telling the brain what's happening in the gut, the lungs, the heart, and the immune system. When that information is consistently alarming — because the gut is inflamed, the mast cells are firing, the terrain is degraded — the brain responds by keeping the nervous system in a defensive state.

You can't just "vagal tone" your way out of this with humming and cold showers. You have to change what the vagus nerve is reporting. That means fixing the gut. Calming the immune activation. Restoring the terrain. And also doing direct nervous system training — which is where HRV biofeedback and structured breathwork come in.

One practice I recommend to every patient in our community: count your breaths to 100. Every day. For 100 days. It sounds absurdly simple, and it is — but it builds the kind of sustained, low-intensity vagal engagement that a dysregulated nervous system actually needs. Not a 5-minute app session. A daily practice with a long enough runway to retrain the system.

Autoimmunity and neuroinflammation: downstream consequences

When the immune system has been activated for long enough — years of infection, years of aggressive treatment, years of mast cell chaos — it starts losing the ability to distinguish self from threat. Joints swell without infection. Antibodies target thyroid tissue, nerve tissue, joint tissue. This isn't a new disease. It's the final stage of an immune system that has been pushed past its capacity for tolerance.

The same logic applies to neurological concerns. Chronic neuroinflammation — driven by gut permeability, mast cell activation, and persistent immune activation — creates real risk for cognitive decline, neuropathy, and neuropsychiatric symptoms. I'm not saying this to scare you. I'm saying it because acknowledging the risk is what allows you to reduce it.

The approach isn't immunosuppression — which is the conventional reflex. The approach is restoring immune tolerance by addressing the upstream drivers: stabilize the gut, calm the mast cells, restore terrain temperature, and protect sleep. These are the same terrain fundamentals from earlier in this series, now applied to higher-stakes territory. The botanical support for gut ecology isn't a luxury add-on — it's foundational to every pattern I've described.

Audrey: Five specialists, twelve medications, one grocery bag of supplements

Clinical details shared with patient permission. Individual outcomes depend on many factors and are not guaranteed.

The 100-breath daily practice

This is the simplest and most effective autonomic retraining tool I know. It costs nothing, requires no equipment, and you can do it anywhere.

This practice, along with detailed guidance on botanical foot soaks and abdominal self-massage, is covered in full inside the Gut Brain Synchrony community.

One terrain.
One coherent plan.

The full masterclass walks through each multi-system pattern with real clinical cases, tongue diagnosis images, and the sequencing logic that tells you what to address first. Watch it free inside the Gut Brain Synchrony community. Up next in this final installment: What if I Don't Improve?

1. Weinstock LB, Pace LA, Rezaie A, et al. (2020). Mast cell activation syndrome: A primer for the gastroenterologist. Digestive Diseases and Sciences. PMID:32328892
2. Lehrer S, Rheinstein PH. (2022). Heart rate variability biofeedback improves clinical outcomes in diseases of dysregulation. Journal of Clinical Medicine, 11(19), 5927. doi:10.3390/jcm11195927
3. Afari N, et al. (2023). HRV biofeedback for chronic fatigue and long COVID: A feasibility trial. ClinicalTrials.gov. NCT05793736